|

ADT (Standard of Care) Clinical Trials

2 actively recruiting trials across 1 location

Also known as: LHRH agonists, LHRH antagonists

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • University of Miami1
  • UNICANCER1

Indications

  • Prostate Cancer2
  • Cancer2
  • High Risk Prostate Carcinoma1

Other1 trial

Study Evaluating the Efficacy and Safety of Darolutamide and Stereotactic Dose Escalated Radiotherapy in Patients With Localized Prostate Cancer and High-risk Features of Relapse
Phase 3

Miami, Florida1 trial

The University of Miami Adapt (UAdapt) Trial

University of Miami

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.